top of page
TOSCA
Three Or Six Colon Adjuvant
A RANDOMIZED TRIAL INVESTIGATING THE ROLE OF FOLFOX-4 OR XELOX (3 VERSUS 6 MONTHS) REGIMEN DURATION AND BEVACIZUMAB AS ADJUVANT THERAPY FOR PATIENTS WITH STAGE II/III COLON CANCER
· Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin
Scarica il file
· NEWSLETTER
Scarica il file
bottom of page